Neuronetics, Inc. SEC filings STIM
Neuronetics, Inc. has 719 filings in SEC EDGAR's recent list, going back to Apr 15, 2003. Its latest annual report, Form 10-K, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Nov 2, 2026 | Oct 30, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 24, 2026 | — |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| 144 | Notice of proposed sale | Aug 18, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Aug 17, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| S-8 | Employee stock plan registration | Aug 11, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 4, 2026 | — |
| 4 | Insider transaction | Jul 23, 2026 | Jul 23, 2026 |
| 3 | Initial insider ownership | Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 20, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 15, 2026 | Jul 14, 2026 |
| 3 | Initial insider ownership | Jul 13, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | May 28, 2026 |
| 144 | Notice of proposed sale | Jun 8, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 29, 2026 | — |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 4 | Insider transaction | May 29, 2026 | May 28, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2026 | May 28, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 27, 2026 | — |
| 8-K |
Current report
Officer or director change
|
May 22, 2026 | May 18, 2026 |
| 4/A | Filing | May 21, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 19, 2026 |
| 3 | Initial insider ownership | May 13, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 13, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2026 | May 5, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| EFFECT | Filing | Apr 10, 2026 | — |
| DEFA14A | Additional proxy material | Apr 9, 2026 | — |
| DEF 14A | Proxy statement | Apr 9, 2026 | May 28, 2026 |
| CORRESP | Letter to the SEC | Apr 8, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 8, 2026 | — |
| 8-K |
Current report
Material agreement, Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Apr 6, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Jul 10, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Mar 31, 2026 | — |
| 4 | Insider transaction | Mar 30, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Mar 30, 2026 | Mar 27, 2026 |
| 4 | Insider transaction | Mar 27, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 24, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 24, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 24, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 23, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 23, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 144 | Notice of proposed sale | Mar 19, 2026 | — |
| 144 | Notice of proposed sale | Mar 19, 2026 | — |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| UPLOAD | Letter from the SEC | Mar 18, 2026 | — |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 18, 2026 | — |
| S-3 | Shelf registration | Mar 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 17, 2026 | — |
| 10-K | Annual report | Mar 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 17, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 8-K |
Current report
Material agreement
|
Mar 2, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 144 | Notice of proposed sale | Feb 26, 2026 | — |
| 144 | Notice of proposed sale | Feb 26, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 25, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 25, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 144 | Notice of proposed sale | Feb 12, 2026 | — |
| 144 | Notice of proposed sale | Feb 12, 2026 | — |
| 8-K |
Current report
Results of operations
|
Feb 10, 2026 | Feb 10, 2026 |
| 144 | Notice of proposed sale | Feb 10, 2026 | — |
| 144 | Notice of proposed sale | Feb 10, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 4, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jan 22, 2026 | Jan 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 6, 2026 | Dec 30, 2025 |
| 4 | Insider transaction | Dec 31, 2025 | Dec 30, 2025 |
| 4 | Insider transaction | Dec 31, 2025 | Dec 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 24, 2025 | — |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 4, 2025 | Nov 4, 2025 |
| 4 | Insider transaction | Oct 22, 2025 | Oct 20, 2025 |
| 4 | Insider transaction | Oct 22, 2025 | Oct 20, 2025 |
| 4 | Insider transaction | Oct 22, 2025 | Oct 20, 2025 |
| 4 | Insider transaction | Oct 22, 2025 | Oct 20, 2025 |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 12, 2025 | — |
| 144 | Notice of proposed sale | Aug 8, 2025 | — |
| 144 | Notice of proposed sale | Aug 8, 2025 | — |
| 144 | Notice of proposed sale | Aug 8, 2025 | — |
| 144 | Notice of proposed sale | Aug 7, 2025 | — |
| 424B5 | Prospectus supplement | Aug 6, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| EFFECT | Filing | Jul 18, 2025 | — |
| CORRESP | Letter to the SEC | Jul 16, 2025 | — |
| 3 | Initial insider ownership | Jul 15, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 15, 2025 | Jul 15, 2025 |
| UPLOAD | Letter from the SEC | Jul 9, 2025 | — |
| S-3 | Shelf registration | Jul 3, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 14, 2025 | May 12, 2025 |
| 144 | Notice of proposed sale | May 13, 2025 | — |
| 144 | Notice of proposed sale | May 12, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
May 6, 2025 | May 6, 2025 |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEF 14A | Proxy statement | Apr 10, 2025 | May 22, 2025 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2025 | Mar 27, 2025 |
| 8-K/A |
Amended current report
Results of operations, Regulation FD disclosure
|
Mar 27, 2025 | Mar 4, 2025 |
| 4/A | Filing | Mar 13, 2025 | Feb 24, 2025 |
| 4/A | Filing | Mar 13, 2025 | Feb 24, 2025 |
| 4/A | Filing | Mar 13, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 6, 2025 | Mar 4, 2025 |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 144 | Notice of proposed sale | Mar 4, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 4, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 144 | Notice of proposed sale | Feb 19, 2025 | — |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 144 | Notice of proposed sale | Feb 18, 2025 | — |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 144 | Notice of proposed sale | Feb 14, 2025 | — |
| 144 | Notice of proposed sale | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 144 | Notice of proposed sale | Feb 12, 2025 | — |
| 144 | Notice of proposed sale | Feb 12, 2025 | — |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| 144 | Notice of proposed sale | Feb 10, 2025 | — |
| 144 | Notice of proposed sale | Feb 10, 2025 | — |
| 144 | Notice of proposed sale | Feb 10, 2025 | — |
| 424B5 | Prospectus supplement | Feb 10, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 10, 2025 | Feb 7, 2025 |
| 424B5 | Prospectus supplement | Feb 6, 2025 | — |
| 8-K/A | Amended current report | Feb 6, 2025 | Dec 10, 2024 |
| S-8 | Employee stock plan registration | Feb 4, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 3 | Initial insider ownership | Dec 19, 2024 | Dec 10, 2024 |
| 3 | Initial insider ownership | Dec 19, 2024 | Dec 10, 2024 |
| 3 | Initial insider ownership | Dec 19, 2024 | Dec 10, 2024 |
| SC 13D | Ownership over 5% (active) | Dec 17, 2024 | — |
| 4 | Insider transaction | Dec 12, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Dec 12, 2024 | Dec 10, 2024 |
| 4 | Insider transaction | Dec 12, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 8-K/A |
Amended current report
Results of operations
|
Nov 13, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 12, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Exit or restructuring costs
|
Nov 12, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2024 | Nov 12, 2024 |
| DEFA14A | Additional proxy material | Nov 1, 2024 | — |
| 8-K |
Current report
Material agreement
|
Nov 1, 2024 | Nov 1, 2024 |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
| DEFA14A | Additional proxy material | Oct 9, 2024 | — |
| 144 | Notice of proposed sale | Oct 8, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- STIM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Malvern, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1227636
- Former names
- Neuronetics, Inc. (until Nov 4, 2026); NEURONETICS INC (until Aug 16, 2006)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.